Sevelamer Carbonate
36 NDCs across 19 manufacturers|33 Generic,3 Brand
Sevelamer Carbonate is used to treat hyperphosphatemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 19, 2007, and the first generic was approved Jun 13, 2017. FDA's Orange Book lists 24 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $180 million on Sevelamer Carbonate across 794,000 claims for 210,000 beneficiaries.
Sevelamer Carbonate is available as 36 NDCs from 19 manufacturers (33 generic, 3 brand), with NADAC prices from $0.21 to $17.19 per EA — the most expensive product costs about 80× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
36
33G / 3B
Manufacturers
19
competing in market
Price Spread
$0.21 – $17.19
per EA
7d Activity
avg -2.8% WoW · of 36 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Genzyme Corporation manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Phosphate Binder class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
19 manufacturers producing SEVELAMER CARBONATE(1 pricing outlier)
Frequently Asked Questions
What is Sevelamer Carbonate used to treat?
Sevelamer Carbonate is used to treat hyperphosphatemia, per the National Library of Medicine's MED-RT classification.
When did Sevelamer Carbonate become available as a generic?
FDA approved the first generic Sevelamer Carbonate (ANDA) on Jun 13, 2017. The Orange Book currently lists 24 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Sevelamer Carbonate?
In 2024, Medicare Part D spent $180 million on Sevelamer Carbonate across 794,000 claims for 210,000 beneficiaries.
How many Sevelamer Carbonate products are on the market?
The Sevelamer Carbonate drug market contains 36 NDCs from 19 manufacturers — 33 generic and 3 brand products.
What is the price range for Sevelamer Carbonate?
NADAC reference prices for Sevelamer Carbonate range from $0.2140 to $17.1932 per EA — the most expensive product costs about 80× the cheapest.
Is generic Sevelamer Carbonate cheaper than brand?
The average generic NADAC for Sevelamer Carbonate is $0.5652 per EA, versus $13.3447 for brand-labeled products — brand versions average about 24× the generic price.
Which manufacturers make Sevelamer Carbonate?
19 manufacturers list Sevelamer Carbonate in NADAC. Ranked by number of NDCs, the largest are Genzyme Corporation (3), Sanofi-Aventis U.S. LLC (3), Strides Pharma Inc. (3), Macleods Pharmaceuticals Limited (3), Aurobindo Pharma Limited (3).
How has the price of Sevelamer Carbonate changed recently?
Over the past 7 days, 0 Sevelamer Carbonate NDCs rose and 28 fell, with a market-wide average change of -2.8%.